Daily Archives: March 5, 2015

Communications in a Biosimilar Age Almost Upon Us

When policy changes, communications must support the change by informing the stakeholders how it impacts them and the decisions they will have to make. When it comes to biosimilars, now is such a time. The question is – who does … Continue reading

Posted in FDA Policy | Comments Off on Communications in a Biosimilar Age Almost Upon Us